283 related articles for article (PubMed ID: 24279335)
1. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
2. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of small molecule Rac1 inhibitors.
Arnst JL; Hein AL; Taylor MA; Palermo NY; Contreras JI; Sonawane YA; Wahl AO; Ouellette MM; Natarajan A; Yan Y
Oncotarget; 2017 May; 8(21):34586-34600. PubMed ID: 28410221
[TBL] [Abstract][Full Text] [Related]
4. Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.
Cai K; Mulatz K; Ard R; Nguyen T; Gee SH
BMC Cancer; 2014 Mar; 14():208. PubMed ID: 24646293
[TBL] [Abstract][Full Text] [Related]
5. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
6. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Rac1/PAK1/LIMK1/cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy.
Wufuer R; Ma HX; Luo MY; Xu KY; Kang L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102143. PubMed ID: 33307230
[TBL] [Abstract][Full Text] [Related]
8. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
9. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways.
Jaffe T; Schwartz B
Int J Cancer; 2008 Dec; 123(11):2543-56. PubMed ID: 18767036
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
12. Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity.
de Toledo M; Anguille C; Roger L; Roux P; Gadea G
PLoS One; 2012; 7(11):e48344. PubMed ID: 23144867
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.
Hong L; Kenney SR; Phillips GK; Simpson D; Schroeder CE; Nöth J; Romero E; Swanson S; Waller A; Strouse JJ; Carter M; Chigaev A; Ursu O; Oprea T; Hjelle B; Golden JE; Aubé J; Hudson LG; Buranda T; Sklar LA; Wandinger-Ness A
J Biol Chem; 2013 Mar; 288(12):8531-8543. PubMed ID: 23382385
[TBL] [Abstract][Full Text] [Related]
14. The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation.
Aslan JE; Baker SM; Loren CP; Haley KM; Itakura A; Pang J; Greenberg DL; David LL; Manser E; Chernoff J; McCarty OJ
Am J Physiol Cell Physiol; 2013 Sep; 305(5):C519-28. PubMed ID: 23784547
[TBL] [Abstract][Full Text] [Related]
15. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis.
Wang G; Beier F
J Bone Miner Res; 2005 Jun; 20(6):1022-31. PubMed ID: 15883643
[TBL] [Abstract][Full Text] [Related]
16. Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.
Friesland A; Zhao Y; Chen YH; Wang L; Zhou H; Lu Q
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1261-6. PubMed ID: 23284167
[TBL] [Abstract][Full Text] [Related]
17. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT transcription factors by the Rho-family GTPases.
Corry J; Mott HR; Owen D
Biochem Soc Trans; 2020 Oct; 48(5):2213-2227. PubMed ID: 32915198
[TBL] [Abstract][Full Text] [Related]
19. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
20. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]